<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F76CCF25-D78C-4A56-9919-660D46FC27E6"><gtr:id>F76CCF25-D78C-4A56-9919-660D46FC27E6</gtr:id><gtr:firstName>Shamanthi</gtr:firstName><gtr:surname>Jayasooriya</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U190092703"><gtr:id>8AED56A7-0D5B-4933-BCB9-8295D6897C2F</gtr:id><gtr:title>An investigation into the effects of Plasmodium falciparum infection on cellular responses to Epstein Barr Virus</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U190092703</gtr:grantReference><gtr:abstractText>Malaria is one of the common diseases in African children, and is caused by parasites carried by some mosquitoes. The parasite enters red blood cells and damages them. It can also affect the way the body reacts to other infections. Epstein Barr Virus is a small germ that commonly infects children. It is very different from malaria and usually causes a mild illness, which often goes unnoticed and gets better without treatment. The Epstein Barr Virus remains in the body, but normally causes no further problems in a healthy person. During malaria infections the bodies control of Epstein Barr Virus can be lost and the virus can begin to cause illnesses. This in some cases leads to the development of a cancer of the jaw seen commonly in children in Africa called Burkitts Lymphoma. If we gain a better understanding of how Malaria infection makes children unable to fight Epstein Barr Virus infection we will be better able to find new treatments and preventative measures for Epstein Barr Virus related illnesses. Blood samples obtained from children with acute malaria infection, at the time of presentation and during convalescence will be used to measure immune responses to Epstein Barr Virus and determine whether there is a deficit in theses responses during the acute malaria infection. If a deficit is seen we will then go onto explore reasons why this might be.</gtr:abstractText><gtr:technicalSummary>The endemic form of Burkitts lymphoma (BL) discovered in Africa is strongly associated with Epstein Barr Virus (EBV) unlike its subsequently discovered sporadic and HIV associated counterparts. The endemic BL regions of Africa coincide with holoendemic malaria areas and have high prevalence rates of early EBV infection. EBV establishes a life-long latent infection in B-lymphocytes and is controlled by cytotoxic CD8 T cells. Previous studies suggest that P.falciparum infection suppresses the function of EBV-specific cytotoxic T cells. We aim to carry out the long overdue exploration of these cellular responses to EBV in order to confirm whether or not there is a true reduction in EBV specific T cell responses during acute malaria infections. This will be done by taking samples of blood from children with mild malaria before and after treatment and enumerating and comparing their immune responses to EBV at these time points. In order to determine if the immune response to EBV is recovered 28 days after treatment is started immune responses at this point will be compared to healthy control children. If our findings confirm what we suspect in a second phase of the study we will explore in vitro mechanisms which could account for the loss of host cellular responses to EBV. Specifically we hope to explore whether the following play a role in impairing EBV specific T cell responses during acute malaria infection using a healthy adult donor in vitro system. 1) P falciparum induced T regulatory cells. 2) Soluble factors derived from Dendritic Cells (DCs) exposed to P.falciparum infected red blood cells This project will describe the changes in EBV specific cellular immunity during acute malaria infection and dependent on these findings explore further mechanistic hypotheses to explain these. In doing so, it will aid understanding of the pathogenesis of endemic Burkitts lymphoma and the immunosuppressive properties of malaria.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-06-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2052264</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Life and Environmental Sciences</gtr:department><gtr:description>The effect of P.falciparum infection on immune responses to EBV</gtr:description><gtr:id>8B5A4D2F-0A3A-4EC3-9D3A-31B3218F9D0C</gtr:id><gtr:impact>Publication in a peer reviewed journal. 
 Revisiting the Effect of Acute P. falciparum Malaria on Epstein-Barr Virus: Host Balance in the Setting of Reduced Malaria Endemicity Shamanthi Jayasooriya, Andrew Hislop, Yanchun Peng, Debbie Croom-carter, Ya Jankey, Andrew Bell, Tao Dong, Sarah Rowland-Jones, Alan Rickinson, Michael Walther, Hilton Whittle
PLoS ONE: Research Article, published 08 Feb 2012 10.1371/journal.pone.0031142</gtr:impact><gtr:outcomeId>CADsKRwwfG6-1</gtr:outcomeId><gtr:partnerContribution>My PhD is currently registerd a the University of Birmingham and two of my senior supervisors are working at this institution.</gtr:partnerContribution><gtr:piContribution>Recruitment of malaria infected children and analysis of their blood samples using a variety of immunological techniques - ELISPOT, Flow cytometry using MHC Class I tetramers, EBV genome load measurements.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BE1E53D2-225E-4BFB-AEAD-F1C08F8F82D3</gtr:id><gtr:title>Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51f09ae31d36a289662577675db5ec78"><gtr:id>51f09ae31d36a289662577675db5ec78</gtr:id><gtr:otherNames>Jayasooriya S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>58d18fee2f2115.75596166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04950B47-2D2B-4AC2-A825-55CDCB2C480B</gtr:id><gtr:title>Plasmodium Infection Is Associated with Impaired Hepatic Dimethylarginine Dimethylaminohydrolase Activity and Disruption of Nitric Oxide Synthase Inhibitor/Substrate Homeostasis.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/050bffc65c8424ce1a92bf9d7d2e78d0"><gtr:id>050bffc65c8424ce1a92bf9d7d2e78d0</gtr:id><gtr:otherNames>Chertow JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>58d190626bccc1.12707559</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U190092703</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>